Palada, Amir I.
HRN: 22-11-66 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2022
CEFTRIAXONE 1G (VIAL)
10/26/2022
11/02/2022
IV
1g
Q12
Soft Tissue Injury
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes